Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $34.1 million.

  • Myomo's Liabilities and Shareholders Equity rose 10889.9% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.9 million, marking a year-over-year increase of 14504.29%. This contributed to the annual value of $42.2 million for FY2024, which is 18970.88% up from last year.
  • Latest data reveals that Myomo reported Liabilities and Shareholders Equity of $34.1 million as of Q3 2025, which was up 10889.9% from $38.7 million recorded in Q2 2025.
  • Myomo's Liabilities and Shareholders Equity's 5-year high stood at $42.2 million during Q4 2024, with a 5-year trough of $10.2 million in Q4 2022.
  • In the last 5 years, Myomo's Liabilities and Shareholders Equity had a median value of $17.1 million in 2023 and averaged $20.8 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 4943.12% in 2022, then soared by 18970.88% in 2024.
  • Over the past 5 years, Myomo's Liabilities and Shareholders Equity (Quarter) stood at $20.1 million in 2021, then tumbled by 49.43% to $10.2 million in 2022, then skyrocketed by 43.49% to $14.6 million in 2023, then surged by 189.71% to $42.2 million in 2024, then fell by 19.33% to $34.1 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $34.1 million for Q3 2025, versus $38.7 million for Q2 2025 and $40.9 million for Q1 2025.